Global Gene Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Gene Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Gene Therapy
1.2 Classification of Gene Therapy by Type
1.2.1 Overview: Global Gene Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gene Therapy Revenue Market Share by Type in 2020
1.2.3 Viral Gene Therapy
1.2.4 Non-Viral Gene Therapy
1.3 Global Gene Therapy Market by Application
1.3.1 Overview: Global Gene Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Global Gene Therapy Market Size & Forecast
1.5 Global Gene Therapy Market Size and Forecast by Region
1.5.1 Global Gene Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gene Therapy Market Size by Region, (2016-2021)
1.5.3 North America Gene Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Gene Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gene Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Gene Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gene Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gene Therapy Market Drivers
1.6.2 Gene Therapy Market Restraints
1.6.3 Gene Therapy Trends Analysis
2 Company Profiles
2.1 Biogen
2.1.1 Biogen Details
2.1.2 Biogen Major Business
2.1.3 Biogen Gene Therapy Product and Solutions
2.1.4 Biogen Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Biogen Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Gene Therapy Product and Solutions
2.2.4 Novartis Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Gilead Sciences
2.3.1 Gilead Sciences Details
2.3.2 Gilead Sciences Major Business
2.3.3 Gilead Sciences Gene Therapy Product and Solutions
2.3.4 Gilead Sciences Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Gilead Sciences Recent Developments and Future Plans
2.4 Sarepta Therapeutics
2.4.1 Sarepta Therapeutics Details
2.4.2 Sarepta Therapeutics Major Business
2.4.3 Sarepta Therapeutics Gene Therapy Product and Solutions
2.4.4 Sarepta Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
2.5 Alnylam Pharmaceuticals
2.5.1 Alnylam Pharmaceuticals Details
2.5.2 Alnylam Pharmaceuticals Major Business
2.5.3 Alnylam Pharmaceuticals Gene Therapy Product and Solutions
2.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Gene Therapy Product and Solutions
2.6.4 Amgen Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Spark Therapeutics
2.7.1 Spark Therapeutics Details
2.7.2 Spark Therapeutics Major Business
2.7.3 Spark Therapeutics Gene Therapy Product and Solutions
2.7.4 Spark Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Spark Therapeutics Recent Developments and Future Plans
2.8 Akcea Therapeutics
2.8.1 Akcea Therapeutics Details
2.8.2 Akcea Therapeutics Major Business
2.8.3 Akcea Therapeutics Gene Therapy Product and Solutions
2.8.4 Akcea Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Akcea Therapeutics Recent Developments and Future Plans
2.9 bluebird bio
2.9.1 bluebird bio Details
2.9.2 bluebird bio Major Business
2.9.3 bluebird bio Gene Therapy Product and Solutions
2.9.4 bluebird bio Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 bluebird bio Recent Developments and Future Plans
2.10 Sunway Biotech
2.10.1 Sunway Biotech Details
2.10.2 Sunway Biotech Major Business
2.10.3 Sunway Biotech Gene Therapy Product and Solutions
2.10.4 Sunway Biotech Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Sunway Biotech Recent Developments and Future Plans
2.11 SIBIONO
2.11.1 SIBIONO Details
2.11.2 SIBIONO Major Business
2.11.3 SIBIONO Gene Therapy Product and Solutions
2.11.4 SIBIONO Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 SIBIONO Recent Developments and Future Plans
2.12 AnGes
2.12.1 AnGes Details
2.12.2 AnGes Major Business
2.12.3 AnGes Gene Therapy Product and Solutions
2.12.4 AnGes Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 AnGes Recent Developments and Future Plans
2.13 Orchard Therapeutics
2.13.1 Orchard Therapeutics Details
2.13.2 Orchard Therapeutics Major Business
2.13.3 Orchard Therapeutics Gene Therapy Product and Solutions
2.13.4 Orchard Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Orchard Therapeutics Recent Developments and Future Plans
2.14 Human Stem Cells Institute
2.14.1 Human Stem Cells Institute Details
2.14.2 Human Stem Cells Institute Major Business
2.14.3 Human Stem Cells Institute Gene Therapy Product and Solutions
2.14.4 Human Stem Cells Institute Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Human Stem Cells Institute Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gene Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Gene Therapy Players Market Share
3.2.2 Top 10 Gene Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Gene Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gene Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Gene Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gene Therapy Revenue Market Share by Application (2016-2021)
5.2 Gene Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gene Therapy Revenue by Type (2016-2026)
6.2 North America Gene Therapy Revenue by Application (2016-2026)
6.3 North America Gene Therapy Market Size by Country
6.3.1 North America Gene Therapy Revenue by Country (2016-2026)
6.3.2 United States Gene Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Gene Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Gene Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gene Therapy Revenue by Type (2016-2026)
7.2 Europe Gene Therapy Revenue by Application (2016-2026)
7.3 Europe Gene Therapy Market Size by Country
7.3.1 Europe Gene Therapy Revenue by Country (2016-2026)
7.3.2 Germany Gene Therapy Market Size and Forecast (2016-2026)
7.3.3 France Gene Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gene Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Gene Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Gene Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gene Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Gene Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Gene Therapy Market Size by Region
8.3.1 Asia-Pacific Gene Therapy Revenue by Region (2016-2026)
8.3.2 China Gene Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Gene Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Gene Therapy Market Size and Forecast (2016-2026)
8.3.5 India Gene Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gene Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Gene Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gene Therapy Revenue by Type (2016-2026)
9.2 South America Gene Therapy Revenue by Application (2016-2026)
9.3 South America Gene Therapy Market Size by Country
9.3.1 South America Gene Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Gene Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Gene Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gene Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Gene Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Gene Therapy Market Size by Country
10.3.1 Middle East & Africa Gene Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Gene Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gene Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Gene Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Gene Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Gene Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Gene Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Gene Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Gene Therapy Revenue Market Share by Region (2021-2026)
Table 6. Biogen Corporate Information, Head Office, and Major Competitors
Table 7. Biogen Major Business
Table 8. Biogen Gene Therapy Product and Solutions
Table 9. Biogen Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Gene Therapy Product and Solutions
Table 13. Novartis Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 15. Gilead Sciences Major Business
Table 16. Gilead Sciences Gene Therapy Product and Solutions
Table 17. Gilead Sciences Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sarepta Therapeutics Corporate Information, Head Office, and Major Competitors
Table 19. Sarepta Therapeutics Major Business
Table 20. Sarepta Therapeutics Gene Therapy Product and Solutions
Table 21. Sarepta Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Alnylam Pharmaceuticals Major Business
Table 24. Alnylam Pharmaceuticals Gene Therapy Product and Solutions
Table 25. Alnylam Pharmaceuticals Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Amgen Corporate Information, Head Office, and Major Competitors
Table 27. Amgen Major Business
Table 28. Amgen Gene Therapy Product and Solutions
Table 29. Amgen Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Spark Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. Spark Therapeutics Major Business
Table 32. Spark Therapeutics Gene Therapy Product and Solutions
Table 33. Spark Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Akcea Therapeutics Corporate Information, Head Office, and Major Competitors
Table 35. Akcea Therapeutics Major Business
Table 36. Akcea Therapeutics Gene Therapy Product and Solutions
Table 37. Akcea Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. bluebird bio Corporate Information, Head Office, and Major Competitors
Table 39. bluebird bio Major Business
Table 40. bluebird bio Gene Therapy Product and Solutions
Table 41. bluebird bio Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Sunway Biotech Corporate Information, Head Office, and Major Competitors
Table 43. Sunway Biotech Major Business
Table 44. Sunway Biotech Gene Therapy Product and Solutions
Table 45. Sunway Biotech Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. SIBIONO Corporate Information, Head Office, and Major Competitors
Table 47. SIBIONO Major Business
Table 48. SIBIONO Gene Therapy Product and Solutions
Table 49. SIBIONO Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. AnGes Corporate Information, Head Office, and Major Competitors
Table 51. AnGes Major Business
Table 52. AnGes Gene Therapy Product and Solutions
Table 53. AnGes Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Orchard Therapeutics Corporate Information, Head Office, and Major Competitors
Table 55. Orchard Therapeutics Major Business
Table 56. Orchard Therapeutics Gene Therapy Product and Solutions
Table 57. Orchard Therapeutics Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Human Stem Cells Institute Corporate Information, Head Office, and Major Competitors
Table 59. Human Stem Cells Institute Major Business
Table 60. Human Stem Cells Institute Gene Therapy Product and Solutions
Table 61. Human Stem Cells Institute Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Gene Therapy Revenue (USD Million) by Players (2019-2021)
Table 63. Global Gene Therapy Revenue Share by Players (2019-2021)
Table 64. Breakdown of Gene Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Gene Therapy Players Head Office, Products and Services Provided
Table 66. Gene Therapy Mergers & Acquisitions in the Past Five Years
Table 67. Gene Therapy New Entrants and Expansion Plans
Table 68. Global Gene Therapy Revenue (USD Million) by Type (2016-2021)
Table 69. Global Gene Therapy Revenue Share by Type (2016-2021)
Table 70. Global Gene Therapy Revenue Forecast by Type (2021-2026)
Table 71. Global Gene Therapy Revenue by Application (2016-2021)
Table 72. Global Gene Therapy Revenue Forecast by Application (2021-2026)
Table 73. North America Gene Therapy Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Gene Therapy Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Gene Therapy Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Gene Therapy Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Gene Therapy Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Gene Therapy Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Gene Therapy Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Gene Therapy Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Gene Therapy Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Gene Therapy Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Gene Therapy Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Gene Therapy Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Gene Therapy Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Gene Therapy Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Gene Therapy Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Gene Therapy Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Gene Therapy Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Gene Therapy Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Gene Therapy Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Gene Therapy Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Gene Therapy Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Gene Therapy Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Gene Therapy Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Gene Therapy Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Gene Therapy Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Gene Therapy Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Gene Therapy Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Gene Therapy Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Gene Therapy Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Gene Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Gene Therapy Picture
Figure 2. Global Gene Therapy Revenue Market Share by Type in 2020
Figure 3. Viral Gene Therapy
Figure 4. Non-Viral Gene Therapy
Figure 5. Gene Therapy Revenue Market Share by Application in 2020
Figure 6. Neurological Diseases Picture
Figure 7. Cancer Picture
Figure 8. Other Picture
Figure 9. Global Gene Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Gene Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Gene Therapy Revenue Market Share by Region (2016-2026)
Figure 12. Global Gene Therapy Revenue Market Share by Region in 2020
Figure 13. North America Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Gene Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Gene Therapy Market Drivers
Figure 19. Gene Therapy Market Restraints
Figure 20. Gene Therapy Market Trends
Figure 21. Biogen Recent Developments and Future Plans
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Gilead Sciences Recent Developments and Future Plans
Figure 24. Sarepta Therapeutics Recent Developments and Future Plans
Figure 25. Alnylam Pharmaceuticals Recent Developments and Future Plans
Figure 26. Amgen Recent Developments and Future Plans
Figure 27. Spark Therapeutics Recent Developments and Future Plans
Figure 28. Akcea Therapeutics Recent Developments and Future Plans
Figure 29. bluebird bio Recent Developments and Future Plans
Figure 30. Sunway Biotech Recent Developments and Future Plans
Figure 31. SIBIONO Recent Developments and Future Plans
Figure 32. AnGes Recent Developments and Future Plans
Figure 33. Orchard Therapeutics Recent Developments and Future Plans
Figure 34. Human Stem Cells Institute Recent Developments and Future Plans
Figure 35. Global Gene Therapy Revenue Share by Players in 2020
Figure 36. Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Gene Therapy Revenue Market Share in 2020
Figure 38. Global Top 10 Players Gene Therapy Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Gene Therapy Revenue Share by Type in 2020
Figure 41. Global Gene Therapy Market Share Forecast by Type (2021-2026)
Figure 42. Global Gene Therapy Revenue Share by Application in 2020
Figure 43. Global Gene Therapy Market Share Forecast by Application (2021-2026)
Figure 44. North America Gene Therapy Sales Market Share by Type (2016-2026)
Figure 45. North America Gene Therapy Sales Market Share by Application (2016-2026)
Figure 46. North America Gene Therapy Revenue Market Share by Country (2016-2026)
Figure 47. United States Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Gene Therapy Sales Market Share by Type (2016-2026)
Figure 51. Europe Gene Therapy Sales Market Share by Application (2016-2026)
Figure 52. Europe Gene Therapy Revenue Market Share by Country (2016-2026)
Figure 53. Germany Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Gene Therapy Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Gene Therapy Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Gene Therapy Revenue Market Share by Region (2016-2026)
Figure 61. China Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Gene Therapy Sales Market Share by Type (2016-2026)
Figure 68. South America Gene Therapy Sales Market Share by Application (2016-2026)
Figure 69. South America Gene Therapy Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Gene Therapy Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Gene Therapy Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Gene Therapy Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Gene Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Gene Therapy Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111

According to our LPI (LP Information) latest study, the global Gene Therapy market size was valued at US$ 6923.7 million in 2023. With growing demand in downstream market, the Gene Therapy is forecast to a readjusted size of US$ 40340 million by 2030 with a CAGR of 28.6% during review period. The research report highlights the growth potential of the global Gene Therapy market. Gene Therapy are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Hemophilia Gene Therapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Hemophilia Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Hemophilia Gene Therapy market. Hemophilia Gene Therapy are expected to show stable growth in the future market. However, produc......

Global Cell and Gene Therapy CDMO Market (2024 Edition): Analysis By Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication, By Region, By Country: Market Insights and Forecast (2024-2029)

Published: 01-Jan-2024        Price: US 2450 Onwards        Pages: 260

Executive Summary Azoth Analytics has released a research report titled "Global Cell and Gene Therapy CDMO Market (2024 Edition)" which provides a complete analysis of the Global Cell and Gene Therapy CDMO Market industry in terms of market segmentation by Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication (Oncology Diseases, Infectious Diseases, Neurological Disorder, Others) for the historical period of 2019-2022, es......

Global Hemophilia Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 88

According to our (Global Info Research) latest study, the global Hemophilia Gene Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode pr......

Global Gene Expression Analysis Market Status and Outlook 2023-2028

Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 102

Gene expression analyses study the occurrence or activity of the formation of a gene product from its coding gene. It is a sensitive indicator of biological activity wherein a changing gene expression pattern is reflected in a change of biological process. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......

Global Gene Expression Analysis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 125

Market Overview of Global Gene Expression Analysis market: According to our latest research, the global Gene Expression Analysis market looks promising in the next 5 years. As of 2022, the global Gene Expression Analysis market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......

Global Animal Genetics Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120

Report Overview: Animal Genetics is a branch of genetics that studies heredity and variation chiefly in farm animals but also in domestic and wild animals. It is based on general genetic principles and concepts, and it mainly uses the hybrid, cytological, population, ontogenetic, mathematical-statistical, and twin methods of general genetics. Animal breeding or genetics is the area of science where experts are trying to steer the frequency of certain genes by combining the most super......

Global Animal Genetics Market Status and Outlook 2023-2028

Published: 24-Nov-2023        Price: US 3160 Onwards        Pages: 105

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Gene Therapy Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 450

Gene Therapy Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene therapy deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of gene therapy deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter gene therapy deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs